MDCX
Medicus Pharma Ltd.
0.1524$
-4.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -62.9% | -48.0% | +791.3% | -34.9% | -1.3% | +0.2% | +110.9% | -16.4% | -26.4% | +1.2% | +157.3% | |
| – | -62.9% | -65.4% | +1,195.1% | -35.8% | -1.2% | -5.4% | +116.1% | -11.1% | -27.0% | +2.0% | +64.4% | |
| – | -66.3% | -68.5% | +441.9% | +80.5% | -21.5% | -4.4% | +142.8% | -10.4% | -26.7% | +0.2% | +68.0% | |
| – | -66.3% | -68.5% | +441.9% | +80.5% | -21.5% | -4.4% | +142.8% | -10.4% | -26.7% | +0.2% | +68.0% | |
| – | -51.2% | +104.1% | +46.0% | -4.3% | +12.7% | +39.7% | +147.4% | +24.1% | -32.2% | -18.0% | +238.9% | |
| – | -51.2% | +66.4% | +58.6% | -3.4% | +15.8% | +44.6% | +156.1% | +24.7% | -32.0% | -17.9% | +28.3% | |
| – | – | – | +52.6% | +3.5% | +3.5% | +3.4% | +3,910.4% | -97.1% | +2,687.9% | -96.3% | +1,662.6% | |
| – | – | – | – | – | -31.7% | +58.4% | -13.0% | +14.5% | +69.4% | -33.7% | +195.5% | |
| – | – | – | – | – | – | – | – | – | -12.2% | -18.6% | +85,441.6% | |
| – | -68.3% | -154.9% | – | -45.9% | -10.2% | -31.5% | +51.3% | -128.0% | – | – | -193.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | 0.0% | +1.1% | +16.5% | +24.2% | +3.6% | +16.7% | +30.4% | +35.1% | +17.3% | +86.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.